(6S,9AS)-N-BENZYL-6-(4-HYDROXYBENZYL)-4,7-DIOXO-2-((3-(PYRIDIN-2-YL)ISOXAZOL-5-YL)METHYL)-8-(QUINOLIN-5-YLMETHYL)HEXAHYDRO-2H-PYRAZINO(2,1-C)(1,2,4)TRIAZINE-1(6H)-CARBOXAMIDE METHANE SULFONIC ACID
UNII BC3NAR7TV9
Substance Identification & Data
This profile provides standardized clinical and technical data for (6s,9as)-n-benzyl-6-(4-hydroxybenzyl)-4,7-dioxo-2-((3-(pyridin-2-yl)isoxazol-5-yl)methyl)-8-(quinolin-5-ylmethyl)hexahydro-2h-pyrazino(2,1-c)(1,2,4)triazine-1(6h)-carboxamide Methane Sulfonic Acid, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BC3NAR7TV9.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2710292-19-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C40H36N8O5.CH4O3S HRTDXYPAIIXIKY-GVGVJZOBSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (6s,9as)-n-benzyl-6-(4-hydroxybenzyl)-4,7-dioxo-2-((3-(pyridin-2-yl)isoxazol-5-yl)methyl)-8-(quinolin-5-ylmethyl)hexahydro-2h-pyrazino(2,1-c)(1,2,4)triazine-1(6h)-carboxamide Methane Sulfonic Acid. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.